Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension

References

• The Task force for the management of arterial hypertension of the European Society of Hypertension (ESC) and of the European Society of Cardiology (ESC). 2007 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J. 2007;28:1462–1536.
   PubMed Web of Science ®Google Scholar
• Nguyen T, Lau DCW. The obesity epidemic and its impact on hypertension. Canad J Cardiol. 2012;28:326–333.
   PubMed Web of Science ®Google Scholar
• Licata G, Scaglione R, Barbagallo M, Parrinello G, Capuana G, Lipari R, et al. Effect of obesity on left ventricular function studied by radionuclide angiocardiography. Int J Obesity. 1991;15:295–302.
   PubMed Web of Science ®Google Scholar
• Licata G, Scaglione R, Capuana G, Parrinello G, Di Vincenzo D, Mazzola G. Hypertension in obese subjects: A distinct hypertensive subgroup. J Hum Hypertens. 1990; 4:37–41.
   PubMed Web of Science ®Google Scholar
• Scaglione R, Di Chiara MA, Indovina A, Lipari R, Ganguzza A, Parrinello G, et al. Left ventricular diastolic and systolic function in normotensive obese subjects: Influence of degree and duration of obesity. Eur Heart J. 1992;13: 738–742.
   PubMed Web of Science ®Google Scholar
• Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G, et al. Central obesity and hypertension: Relationship between fasting serum insulin, plasma renin activity and diastolic blood pressure in young obese subjects. Am J Hypertens. 1994;7:314–320.
   PubMed Web of Science ®Google Scholar
• De Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, et al. Normalization for body size and population-attributable risk of left ventricular hypertrophy: The Strong Heart Study. Am J Hypertens. 2005;18:191–196.
   PubMed Web of Science ®Google Scholar
• Licata G, Scaglione R, Corrao S, Ganguzza A, Mazzola G, Arnone S, et al. Heredity and obesity-associated hypertension: Impact on hormonal characteristics and left ventricular mass. J Hypertens. 1995, 13:611–618.
   PubMed Web of Science ®Google Scholar
• Parrinello G, Licata A, Colomba D, Di Chiara T, Argano C, Bologna P, et al. Left ventricular filling abnormalities and obesity associated hypertension: Relationship with overproduction of circulating transforming growth factor beta1. J Hum Hypertens. 2005;19:543–550.
   PubMed Web of Science ®Google Scholar
• Scaglione R, Di Chiara T, Cariello T, Licata G. Visceral obesity and metabolic syndrome: Two faces of the same medal?Intern Emerg Med. 2010;5:111–119.
   PubMed Web of Science ®Google Scholar
• Nishida M, Funahashi T, Shimomura I. Pathophysiological significance of adiponectin. Med Mol Morphol. 2007; 40:55–67.
   PubMed Web of Science ®Google Scholar
• Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:134–141.
   Web of Science ®Google Scholar
• Kojima S, Funahashi T, Maruyoshi H, Honda O, Sugiyama S, Kavano H, et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with ateroma. Thromb Res. 2005;115:483–490.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart. 2004;90:528–533.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS. 2006;580:2917–2921.
   PubMed Web of Science ®Google Scholar
• Diez JJ, Iglesias P. The role of novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148:293–300.
   PubMed Web of Science ®Google Scholar
• Di Chiara T, Argano C, Corrao S, Scaglione R, Licata G. Hypoadiponectinemia: A link between visceral obesity and metabolic syndrome. J Nutr Metab. 2012; ID175245:1–7.
   Google Scholar
• Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10: 1384–1389.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi H, Yatsuya H, Tamakowshi K, Matsushita K, Otsuka R, Wada K, et al. Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension. 2007;49: 1448–1454.
   PubMed Web of Science ®Google Scholar
• Crepaldi G, Belfiore F, Bosello O, Caviezel F, Contaldo F, Enzi G, Melchionda N. Special report: Italian Consensus Conference-Overweight, Obesity and Health. Int J Obesity. 1991;15:781–790.
   PubMed Web of Science ®Google Scholar
• Scaglione R, Ganguzza A, Corrao S, Parrinello G, Merlino G, Dichiara MA, et al. Central obesity and hypertension: Pathophysiologic role of renal haemodynamics and function. Int J Obesity. 1995;19:403–409.
   PubMed Web of Science ®Google Scholar
• Pischon T, Hotamisligil GS, Rimm EB. Adiponectin: Stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem. 2003;49:650–652.
   PubMed Web of Science ®Google Scholar
• Corrao S, Parrinello G, Arnone S, Indovina A, Scaglione R, Licata G. Influence of obesity on the echocardiographic evaluation of left ventricular ejection fraction by area- length method: Comparison with radionuclide angiography. J Cardiovasc Diagn Proced. 1993;11:127–134.
   Google Scholar
• Schillaci G, Pirro M. Hypoadiponectinemia: A novel link between obesity and hypertension?Hypertension. 2007;49: 1217–1229.
   PubMed Web of Science ®Google Scholar
• Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003; 16:72–75.
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;43: 1318–1323.
   PubMed Web of Science ®Google Scholar
• Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, et.al. Hypoadiponectinemia as a predictor for the development of hypertension: A 5-year prospective study. Hypertension. 2007;49:1455–1461.
   PubMed Web of Science ®Google Scholar
• Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, et al. Adiponectin replenishment ameliorates obesity- related hypertension. Hypertension. 2006;47:1108–1116.
   PubMed Web of Science ®Google Scholar
• Shunkert H. Obesity and target organ damage: The heart. Int J Obesity. 2002;26 Suppl 4:S15–S20.
   Google Scholar
• Vasan RS. Cardiac function and obesity. Heart. 2003;89: 1127–1129.
   PubMed Web of Science ®Google Scholar
• Heckbert SR, Post W, Pearson GD, Arnett DK, Gomes AS, Jerosch-Herold M, et al. Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: The Multiethnic Study of Atherosclerosis. J Am Coll Cardiol. 2006; 48:2285–2292.
   PubMed Web of Science ®Google Scholar
• Wong CY, O’Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004; 110:3081–3087.
   PubMed Web of Science ®Google Scholar
• Ybarra J, Resmini E, Planas F, Navarro-Lopez F, Webb S, Pou JM, et al. Relationship between adiponectin and left atrium size in uncomplicated obese patients: Adiponectin, a link between fat and heart. Obes Surg. 2009;19:1324–1332.
   PubMed Web of Science ®Google Scholar
• Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular disorders: Disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res. 2007;101:27–39.
   PubMed Web of Science ®Google Scholar
• Hong SJ, Park CG, Seo HS, Oh DJ, Ro YM. Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press. 2004;13:236–242.
   PubMed Web of Science ®Google Scholar
• Lindberg S, Mogelvang R, Pedersen SH, Bjerre M, Frystyk J, Flyvbjerg A et al. Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study). Am J Cardiol. 2013;111:1139–1145.
   PubMed Web of Science ®Google Scholar